Does formalin disinfection reduce bacterial colonization of biopsy needle? A prospective study.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
29 Apr 2024
Historique:
received: 28 02 2024
revised: 04 04 2024
accepted: 16 04 2024
medline: 2 5 2024
pubmed: 2 5 2024
entrez: 1 5 2024
Statut: aheadofprint

Résumé

To investigates the efficacy of formalin disinfection of the needle tip in transrectal prostate biopsy (TRB) procedure to reduce infectious complications. The primary aim is to assess the impact of formalin on bacterial contamination of biopsy needle tip and its association with post-biopsy infective events. We have employed a bacterial culture-based observational cohort design in this study. Two groups, formalin disinfection and non-formalin group, both undergone systematic 12-core TRB. In the formalin group, the biopsy needle tip was immersed in 10% formalin solution after each core, while in the non formalin group no formalin solution immersion was used. The primary outcomes include bacterial growth on biopsy needle tips and post-biopsy infective events. Formalin disinfection significantly reduced bacterial growth on needle tips (p<0.001). The formalin group had no post-biopsy infections or sepsis, while the non-formalin group experienced a 7.5% infective event rate after TRB. Formalin disinfection of biopsy needle tip significantly reduces bacterial growth on biopsy needle and urinary tract infectious complications developed secondary to TRB. Further multicenter randomized controlled studies with larger cohorts are warranted to validate and establish formalin disinfection as a routine practice in TRB procedures.

Identifiants

pubmed: 38692495
pii: S0090-4295(24)00293-0
doi: 10.1016/j.urology.2024.04.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No conflict.

Auteurs

Tuncel Uzel (T)

Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Urology. Electronic address: tunceluzelmd@gmail.com.

Erdem Öztürk (E)

Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Urology. Electronic address: drerdemoz@gmail.com.

Eriz Özden (E)

Ankara University Department of Radiology. Electronic address: erizozden@yahoo.com.

İsa Dağli (İ)

Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Urology. Electronic address: isadaglii@gmail.com.

Nurullah Hamidi (N)

Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Urology. Electronic address: dr.nhamidi86@gmail.com.

Mehmet Duvarci (M)

Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Urology. Electronic address: mehmet_duvarci@hotmail.com.

İpek Mumcuoğlu (İ)

Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Microbiology. Electronic address: ipekmumcuoglu@gmail.com.

Tuba Dal (T)

Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Microbiology. Electronic address: tuba_dal@yahoo.com.

Halil Başar (H)

Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Urology. Electronic address: hbasar@hotmail.com.

Classifications MeSH